Resilient Drug Supply Project

About the Resilient Drug Supply Project

The Resilient Drug Supply Project focuses on the supply chains and global disruptions for the most critical drugs for life-saving and life-sustaining treatment (funded by a gift from the Walton Family Foundation). Outcomes of this research will improve the healthcare supply system’s ability to maintain a steady and adequate supply of critical medicines and supplies worldwide. 

Learn more

RDSP's Critical Drug Shortage Lists

Stay up to date on the latest shortages on the 40 critical COVID-19 drug list and the 156 critical acute drugs list.


Key COVID-19 Supply Chain Issues

Each week we'll update you with the latest COVID-19 supply chain news, but for the latest go to our Twitter @cidrap_rdsp.

RDSP Resource Page

Check out RDSP's US Senate testimony, "Viewpoint" report, and more.


Worker at drug manufacturing plant

New ASPR report bares frayed, fractured US drug supply chains

Report characterizes risks in the 100-day supply chains of 143 essential prescription drugs.

Arm hooked up to IV

Report: US plant closure portends drug shortages—some critical

A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.

Stephen Schondelmeyer, PharmD, PhD

RDSP's Schondelmeyer named to End Drug Shortages Alliance board

The alliance aims to boost transparency, communication, quality, redundancy, and production.

Child in hospital bed

RDSP maps medicine supply to US to predict, prevent shortages (part 2 of 2)

"When prescription drugs are not affordable or accessible for any reason, consumers can experience lost work days, disease...

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Grant support for RDS provided by

Unrestricted financial support provided by

Bentson Foundation